Morgan Stanley Standard Biotools Inc. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Standard Biotools Inc. stock. As of the latest transaction made, Morgan Stanley holds 12,934,541 shares of LAB stock, worth $26.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,934,541
Previous 7,617,876
69.79%
Holding current value
$26.6 Million
Previous $20.6 Million
10.9%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding LAB
# of Institutions
148Shares Held
269MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$132 Million9.8% of portfolio
-
Viking Global Investors LP58.7MShares$121 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$44.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$33 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.7MShares$26.1 Million0.2% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $162M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...